Copeland Capital Management LLC Acquires 72,715 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Copeland Capital Management LLC boosted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 9.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 839,356 shares of the company's stock after purchasing an additional 72,715 shares during the period. U.S. Physical Therapy accounts for approximately 1.4% of Copeland Capital Management LLC's portfolio, making the stock its 20th biggest position. Copeland Capital Management LLC owned about 5.56% of U.S. Physical Therapy worth $74,459,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Quarry LP raised its stake in shares of U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company's stock valued at $48,000 after acquiring an additional 478 shares in the last quarter. KBC Group NV lifted its stake in shares of U.S. Physical Therapy by 68.6% in the third quarter. KBC Group NV now owns 774 shares of the company's stock worth $66,000 after buying an additional 315 shares during the last quarter. Pacer Advisors Inc. bought a new stake in shares of U.S. Physical Therapy during the 4th quarter worth $113,000. First Horizon Advisors Inc. grew its stake in U.S. Physical Therapy by 25.1% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company's stock valued at $126,000 after buying an additional 298 shares during the last quarter. Finally, International Assets Investment Management LLC raised its holdings in U.S. Physical Therapy by 8,414.8% in the 3rd quarter. International Assets Investment Management LLC now owns 2,299 shares of the company's stock worth $195,000 after acquiring an additional 2,272 shares during the period.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. JMP Securities began coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They set an "outperform" rating and a $113.00 price target for the company. JPMorgan Chase & Co. increased their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Tuesday, December 3rd. Barrington Research reaffirmed an "outperform" rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. Bank of America raised U.S. Physical Therapy from a "neutral" rating to a "buy" rating and increased their price objective for the company from $100.00 to $115.00 in a research report on Monday, December 16th. Finally, Citizens Jmp upgraded shares of U.S. Physical Therapy to a "strong-buy" rating in a research note on Monday, December 16th. One analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, U.S. Physical Therapy currently has a consensus rating of "Buy" and a consensus target price of $114.00.

U.S. Physical Therapy Price Performance

Shares of NYSE:USPH traded down $0.43 during midday trading on Wednesday, reaching $88.17. 19,051 shares of the company's stock were exchanged, compared to its average volume of 84,720. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The company's 50 day simple moving average is $91.65 and its two-hundred day simple moving average is $88.52. The firm has a market capitalization of $1.33 billion, a PE ratio of 93.92, a price-to-earnings-growth ratio of 3.65 and a beta of 1.48. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Nancy Ham sold 1,172 shares of the stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $96.72, for a total transaction of $113,355.84. Following the sale, the director now owns 1,112 shares of the company's stock, valued at $107,552.64. This represents a 51.31 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of the stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total transaction of $185,900.00. Following the sale, the director now directly owns 16,726 shares in the company, valued at $1,554,681.70. This trade represents a 10.68 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 7,412 shares of company stock valued at $706,605. Corporate insiders own 1.70% of the company's stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.